Early Detection of Pancreatic Cancer by Hyperpolarized MRI
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Objective

Results

Currently, there are no diagnostic tools for the early detection of pancreatic
cancer; therefore, the primary objective of this project is to develop and
optimize a method of detecting premalignant stages of pancreatic cancer
through hyperpolarized metabolic magnetic resonance imaging. This
technique can increase the sensitivity of conventional magnetic resonance
by over 10,000-fold, enabling real-time metabolic measurements.
Hyperpolarized metabolic magnetic resonance imaging allows for noninvasive investigation of the metabolic flux as pancreatic cancer initiates and
evolves in vivo.
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Figure A: 13C-spectra of KPC mice at preinduction, 10 weeks, and 20 weeks. As demonstrated on the
right-most spectra, the lactate is higher in more advanced pancreatic cancer. Pyruvate to lactate
conversion was visible lower at preinduction and 10 weeks. Figure B: Lactate/pyruvate ratio by mouse
model. At 20 weeks, the KPC model showed a significantly increased ratio compared to the KC and
control mice. Figure C: Mice model lactate/pyruvate ratio compared at 20 weeks. The more aggressive
KPC model leads to a higher ratio, representing a more significant pyruvate to lactate conversion

Summary / Future Direction

Preliminary Data
Average ratio at
time point

Control model (n)

KC model (n)

1 (14 weeks)

0.23672 (7)

0.248053 (3)

0.19819 (4)

2 (21 weeks)

0.144264 (7)

0.258622 (3)

0.336179 (1)

3 (28 weeks)

0.209469 (6)

0.258443 (4)

N/A

Previous research performed in our lab using a
spontaneous mouse models (KC and KPC) it
demonstrated a rise in the lactate/pyruvate ratio
within the more aggressive KPC model; however,
all KPC mice died prior to the third time point.
Though the collected data is promising, we have
since moved to an inducible model in order to
have more control over the initiation of cancer,
and thus providing better data.
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§ Hyperpolarization experiments were performed with 1-13C-labeled
pyruvate containing 15 mM trityl radical (OX63) using a commercial DNP
polarizer (HyperSense, Oxford Instruments, UK) at 3.35T magnetic field
and a temperature of 1.4 Kelvin.
§ 13C-spectra were obtained using a Bruker BioSpec 7T imaging scanner,
which utilized a dual tuned (1H) volume coil and (13C) surface coil (Doty
Scientific, SC). Area under the curve values were collected for each
metabolite and lactate/pyruvate ratios were compared.
§ Three different inducible mice models were used for these studies:
P48CreERT2
(control),
P48CreERT2:LSLKras
(KC),
and
P48CreERT2:LSLKras:LSLP53 (KPC). Mice were imaged at three time
points: preinduction, 10 weeks, and 20 weeks.
§ A tamoxifen induction system was implemented to regulate the mouse
model mutations.

KPC model (n)

§ Hyperpolarized 13C-MRS/MRI is fast
becoming a real-time imaging modality to
non-invasively follow metabolic fluxes in vivo
for early detection of pancreatic cancer.
§ Clinical translation of this technique could
enable physicians to detect pancreatic
cancer at a much earlier stage, thus
improving patient outcomes and survival.
§ At the MD Anderson Cancer Center, we are
initiating a clinical trial for early detection of
pancreatic cancer at the high-risk pancreatic
cancer clinic by utilizing a recently installed
clinical DNP polarizer.
§ Our laboratory plans to collect data from one more time point (30 weeks) using these mice. We are
also in the preliminary stages of incorporating Artificial Intelligence to our metabolic imaging modality
for deep learning-assisted early detection of pancreatic cancer
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